Mirae Asset Global Etfs Holdings Ltd. Axogen, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.4 Billion
- Q1 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Axogen, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 25,185 shares of AXGN stock, worth $275,272. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,185
Previous 24,128
4.38%
Holding current value
$275,272
Previous $397,000
17.13%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding AXGN
# of Institutions
191Shares Held
39.2MCall Options Held
61.7KPut Options Held
42.8K-
First Light Asset Management, LLC Edina, MN4.47MShares$48.9 Million10.62% of portfolio
-
Black Rock Inc. New York, NY3.25MShares$35.5 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.6MShares$28.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.54MShares$27.7 Million0.0% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO1.59MShares$17.4 Million0.54% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $462M
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...